CONMED Corp — Director's Dealing 2022

Mar 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-03-01

Reporting Person: SHAGORY PETER K (EVP, STRAT & CORP DEVT)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-01	Options To Purchase Common Stock	$144.55	A	20000	Acquired	2032-03-01	Common Stock (20000)	Direct

Footnotes

F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period